Andrew Campbell, MD is the Director of the Comprehensive Sickle Cell Disease Program at Children's National Hospital. His research interests span several topics in sickle cell disease including pulmonary complications, fetal hemoglobin switching in transgenic sickle cell mice, phenotype/genotype relationships and renal complications.
Partial Data by Infogroup (c) 2024. All rights reserved.